Skip to content

AptarGroup ATR Payments of Ordinary Dividends, Common Stock

Payments of Ordinary Dividends, Common Stock at other companies

Baxter International logo
Baxter InternationalBAX
$5M-94.3%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
Nordson logo
NordsonNDSN
International Flavors & Fragrances logo
International Flavors & FragrancesIFF

Other financials

Income statement

See full
Revenue$982.9M+10.8%
Gross profit$351.9M+4.6%
Operating income$107.5M-5.2%
Net income$72.7M-7.8%
EPS (diluted)$1.12-4.3%

Balance sheet

See full
Cash & equivalents$225.0M+78.8%
Total debt$1.4B+32.7%
Total equity$2.6B+3.6%
Total assets$5.1B+12.6%

Cash flow

See full
Operating cash flow$118.7M+43.5%
CapEx$65.4M+15.0%
Free cash flow$53.3M+106%

Valuation

See full
Market cap$7.68B-17.9%
Enterprise value$8.89B-13.9%
P/E19.9×-5.4×
P/S-0.6×

Profitability

See full
Gross margin36.7%-1.6pp
Operating margin12.8%-1.2pp
Net margin10%-0.4pp
FCF margin8.4%-2.1pp

Returns & leverage

See full
Return on equity15%-0.2pp
Debt / equity0.5×+0.1×
Current ratio1.7×+0.4×

Where this comes from

Reported directly by AptarGroup in its filing.

Tagged under the XBRL concept us-gaap:PaymentsOfDividendsCommonStock.

The official record: AptarGroup’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about AptarGroup's payments of ordinary dividends, common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AptarGroup's payments of ordinary dividends, common stock?
AptarGroup (ATR) reported payments of ordinary dividends, common stock of $30.92M in Q1 2026.
How has AptarGroup's payments of ordinary dividends, common stock changed year-over-year?
AptarGroup's payments of ordinary dividends, common stock increased by 3.3% year-over-year, from $29.92M to $30.92M.
What is the long-term trend for AptarGroup's payments of ordinary dividends, common stock?
Over 4 years (2021 to 2025), AptarGroup's payments of ordinary dividends, common stock has grown at a 5.2% compound annual growth rate (CAGR), from $98.51M to $120.78M.